ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Results from one CML patient (patient 3) show that sequencing on a single PacBio SMRT cell generated a uniform mapped read coverage of about 10,000X across the entire length of the BCR-ABL1 amplicon (Figure 1B).